New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 3, 2014
09:14 EDTBKS, CYTR, ORCL, FIO, MON, VVUS, LQDT, PLUG, LMCA, CACIOn The Fly: Pre-market Movers
HIGHER: Plug Power (PLUG), up 3% after agreeing to acquire hydrogen fuel cell stack technology developer ReliOn... Fusion-io (FIO), up 2% after announcing a collaboration with Oracle (ORCL) on the development of flash-aware interfaces for MySQL... Monsanto (MON), up 1.5% following upgrades to Overweight at JPMorgan... CytRx (CYTR), up 9.7% after announcing data from a trial that it said supports the current evaluation of aldoxorubicin as a treatment for patients with GBM tumors. LOWER: Liquidity Services (LQDT), down 13% after confirming it withdrew from live auction bidding for the DoD rolling stock contract, shares downgraded to Neutral at RW Baird... Barnes & Noble (BKS), down 9% after Liberty Media (LMCA) agreed to reduce its stake in B&N... VIVUS (VVUS), down 5% following downgrade to Underweight at Piper Jaffray... CACI International (CACI), down 8.7% after cutting its fiscal 2014 earnings and sales outlook, citing reduced government spending and delays in award activity.
News For BKS;LMCA;PLUG;LQDT;VVUS;MON;FIO;ORCL;CYTR;CACI From The Last 14 Days
Check below for free stories on BKS;LMCA;PLUG;LQDT;VVUS;MON;FIO;ORCL;CYTR;CACI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 14, 2014
12:58 EDTLMCAJANA Partners gives quarterly update on stakes
NEW STAKES: Apache (APA), FMC Corp (FMC), Civeo (CVEO), PetSmart (PETM), and Charter Communications (CHTR). INCREASED STAKES: Actavis (ACT), AIG (AIG), Mallinckrodt (MNK), HD Supply (HDS), and American Capital (ACAS). DECREASED STAKES: Liberty (LVNTA), Oil States International (OIS), eBay (EBAY), Liberty Media (LMCA), and Liberty Interactive (LINTA). LIQUIDATED STAKES: Sirius XM (SIRI), Juniper (JNPR), Golar LNG (GLNG), Outerwall (OUTR), and Teva (TEVA).
10:48 EDTPLUGPlug Power CEO says newer units 'far superior' to older ones
Subscribe for More Information
10:05 EDTLMCAOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:11 EDTPLUGOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Kohl's (KSS), up 2.5%... Plug Power (PLUG), up 10%... Perrigo (PRGO), up 4.5%. HIGHER: Aruba Networks (ARUN), up 3% after shares upgraded at Stifel... KaloBios (KBIO), up 7.9% after publication shows EphA3 as target for anticancer therapy... Supernus (SUPN), up 4.4% after receiving FDA fast track designation for SPN-810. DOWN AFTER EARNINGS: Noodles & Company (NDLS), down 22%... Vipshop (VIPS), down 5.8%. LOWER: ExOne (XONE), down 10.7%, Voxeljet (VJET), down 6.6%, after earnings reports. Peers in the 3D space are lower as well, with Stratasys (SSYS) down 1% and 3D Systems (DDD) down 0.2%... Enphase Energy (ENPH), down 2.6% after filing to sell common stock for holders... InterMune (ITMN), down 3% after downgraded at Goldman following yesterday's advance on Bloomberg report that the company received takeover bids from Sanofi (SNY), Roche (RHHBY).
09:07 EDTLMCAMorgan Stanley to hold a conference
Subscribe for More Information
07:05 EDTPLUGPlug Power reports Q2 EPS ex-items (4c), consensus (4c)
Reports Q2 revenue $17.3M, consensus $16.65M. The company shipped 687 units during Q2 compared to 246 units during the same period last year.
06:18 EDTLMCALiberty Media upgraded to Overweight from Equal-Weight at Evercore
Subscribe for More Information
05:57 EDTPLUGStocks with implied volatility movement; PBR PLUG
Subscribe for More Information
August 13, 2014
16:03 EDTORCLOracle extends tender offer for MICROS to September 2
Subscribe for More Information
August 11, 2014
12:47 EDTPLUGPlug Power August volatility elevated into Q2 and outlook
Plug Power August call option implied volatility is at 110, September is at 89, October is at 75, January is at 69; compared to its 26-week average of 84 according to Track Data, suggesting large near term price movement into the expected release of Q2 on August 14.
08:25 EDTPLUGPlug Power volatility elevated into Q2 and outlook
Plug Power August call option implied volatility is at 100, September is at 96, October is at 86, January is at 76; compared to its 26-week average of 83 according to Track Data, suggesting large near term price movement into the expected release of Q2 on August 14.
August 9, 2014
16:26 EDTORCLOracle sues Oregon over dispute with state's health-insurance exchange, WSJ says
Subscribe for More Information
August 8, 2014
07:06 EDTBKSSamsung, Barnes & Noble holding press event on August 20, Business Insider says
Subscribe for More Information
August 7, 2014
16:21 EDTVVUSVIVUS reports Q2 EPS (25c), consensus (28c)
Subscribe for More Information
15:02 EDTPLUG Plug Power volatility elevated on wide price movement
Subscribe for More Information
07:03 EDTLQDTLiquidity Services sees Q4 adjusted EPS 13c-19c, consensus 27c
Sees Q4 adjusted EBITDA $9.0M-$12.0M.
07:02 EDTLQDTLiquidity Services lowers 2014 adjusted EPS view to $1.00-$1.06 from $1.10-$1.27
Subscribe for More Information
07:00 EDTLQDTLiquidity Services reports Q3 adjusted EPS 31c, consensus 27c
Subscribe for More Information
06:36 EDTBKSGoogle, Barnes & Noble launching same-day book delivery service, NY Times says
Google (GOOG) and Barnes & Noble (BKS) today will begin allowing consumers in three cities to order books carried by Barnes & Noble stores and have them delivered to their homes on the same day, according to The New York Times. Users will order the books on Google Shopping Express, and the service will compete with Amazon, the newspaper stated. Reference Link
06:06 EDTCYTRCytRx's aldoxorubicin for sarcomashows positive Phase 2b clinical trial results
CytRx's oral presentation titled “Randomized phase 2b trial comparing first-line treatment with aldoxorubicin versus doxorubicin in patients with advanced soft tissue sarcomas,” was featured in The Lancet Oncology in its July issue. The updated results from CytRx’s ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable STS demonstrated that aldoxorubicin significantly increases progression-free survival, PFS at 6 months, overall response rate and tumor shrinkage, compared to doxorubicin, the current standard-of-care, as a first-line treatment in patients with STS. The data trended in favor of aldoxorubicin for all of the major subtypes of STS. The company is on track to report the full overall survival results from this trial prior to year-end.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use